The faulty brake pedal can increase the risk of injury or crash, according to the National Highway Traffic Safety Administration.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety update regarding ELEVIDYS ...

Evaluating and Enhancing Immunosuppressive Regimen: As part of a comprehensive review of safety data ... Immunity against AAVrh74: In AAV-vector based gene therapies, preexisting anti-AAV ...

That’s the view of analysts at Jefferies, who suggest it could “re-ignite concerns over the use of lentiviral vectors and the risk of secondary (vector-mediated) cancer".